Randall E. Kaye

2022

In 2022, Randall E. Kaye earned a total compensation of $1.4M as Executive Vice President and Chief Medical Officer at Longboard Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$198,000
Option Awards$827,115
Salary$351,563
Other$9,150
Total$1,385,828

Kaye received $827.1K in option awards, accounting for 60% of the total pay in 2022.

Kaye also received $198K in non-equity incentive plan, $351.6K in salary and $9.2K in other compensation.

Rankings

In 2022, Randall E. Kaye's compensation ranked 2,393rd out of 5,676 executives tracked by ExecPay. In other words, Kaye earned more than 57.8% of executives.

ClassificationRankingPercentile
All
2,393
out of 5,676
58th
Division
Manufacturing
1,312
out of 3,084
58th
Major group
Chemicals And Allied Products
585
out of 1,399
58th
Industry group
Drugs
540
out of 1,300
59th
Industry
Pharmaceutical Preparations
389
out of 942
59th
Source: SEC filing on April 11, 2023.

Kaye's colleagues

We found two more compensation records of executives who worked with Randall E. Kaye at Longboard Pharmaceuticals in 2022.

2022

Kevin Lind

Longboard Pharmaceuticals

Chief Executive Officer

2022

Brandi Roberts

Longboard Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like